L. M. Sigman

Phase I clinical and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered as a five-day continuous infusion.

M. Egorin, D. V. Van Echo, J. Aisner, 1987, Cancer research.

Human pharmacokinetics, excretion, and metabolism of the anthracycline antibiotic menogaril (7-OMEN, NSC 269148) and their correlation with clinical toxicities.

M. Egorin, D. V. Van Echo, J. Aisner, 1986, Cancer research.

Phase I Clinical and Pharmacokinetic Study of Hexamethylene Bisacetamide (NSC 95580) Administered as a Five-Day Continuous Infusion1

M. Egorin, J. Aisner, A. Forrest, 2006 .

Phase I trial of N-methylformamide (NMF, NSC 3051).

P. O'dwyer, D. V. Van Echo, J. Aisner, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Rapid progression of Barrett's esophagus to metastatic esophageal carcinoma in a patient with chronic lymphocytic leukemia.

B. Krevsky, L. M. Sigman, C. Hsu, 1998, Journal of clinical gastroenterology.

Phase I trial of menogaril administered as an intermittent daily infusion for 5 days.

M. Egorin, D. V. Van Echo, J. Aisner, 1986, Cancer treatment reports.